Study S002334

Randomized, Placebo-Controlled, Single-Dose, Crossover Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-686117 in Subjects With Type 2 Diabetes

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT00508287
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: DOUBLE
Status: COMPLETED
Enrollment: 36
Start: 2007-08
Primary completion: 2007-11
Lead sponsor: Bristol-Myers Squibb
Conditions: Type 2 Diabetes
Interventions: DRUG:BMS-686117; DRUG:Byetta; DRUG:Placebo
Results posted: FALSE

Registered primary outcomes

Safety: incidence of adverse events [from subject enrollment to study discharge]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.